Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China flag China · Delayed Price · Currency is CNY
10.07
+0.10 (1.00%)
May 19, 2026, 10:25 AM CST

SHE:300439 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
571.68657.57728.64958.88806.41666.31
Short-Term Investments
--10.12---
Trading Asset Securities
255.76265.43161.08680.17100.7
Cash & Short-Term Investments
827.43923899.84964.88886.58767.01
Cash Growth
6.01%2.57%-6.74%8.83%15.59%133.70%
Accounts Receivable
610.01581.6557.16569.92816.36827.94
Other Receivables
11.7310.8815.5636.3275.6945.9
Receivables
621.73592.48572.72606.24892.05873.84
Inventory
250.58231.07286.01259.01218.03211.39
Other Current Assets
146.66146.1265.6369.0374.88157.7
Total Current Assets
1,8461,8931,8241,8992,0722,010
Property, Plant & Equipment
1,2031,2101,4161,1781,0651,048
Long-Term Investments
163.04163.35190.73160.94162.7184.38
Other Intangible Assets
123.7126.89135.43127.85120.19148.37
Long-Term Deferred Tax Assets
55.4852.7740.7535.5325.5541.11
Long-Term Deferred Charges
27.2429.7539.8234.3418.635.24
Other Long-Term Assets
175.32178.1857.9453.05119.82125.81
Total Assets
3,5943,6543,7053,4893,5843,593
Accounts Payable
329.59356.41369.41333.46374.26331.34
Accrued Expenses
44.8473.93102.97109.57123.02129.15
Short-Term Debt
-2030.0250.05217.76340.22
Current Portion of Long-Term Debt
11.9211.48-7.0463.1252.12
Current Portion of Leases
--15.7912.4816.7518.86
Current Income Taxes Payable
13.5219.049.6215.9110.815.41
Current Unearned Revenue
48.3955.8563.7888.2775.4537.93
Other Current Liabilities
85.7487.2975.8582.34100.13136.17
Total Current Liabilities
534.01623.99667.44699.13981.31,061
Long-Term Debt
----7.0445.03
Long-Term Leases
26.2527.7437.1123.626.9725.64
Long-Term Unearned Revenue
25.7625.9617.029.92.329.39
Long-Term Deferred Tax Liabilities
25.522746.2848.4234.9861.19
Other Long-Term Liabilities
1.371.373.81.4511.62-
Total Liabilities
612.91706.06771.65782.491,0641,202
Common Stock
384.32384.32383.95383383383
Additional Paid-In Capital
1,1201,1211,1201,1091,1171,117
Retained Earnings
1,5031,4701,4581,2521,035872.85
Treasury Stock
-2.91-2.91-5.82---
Comprehensive Income & Other
-17.58-17.95-16.94-29.14-24.69-25.59
Total Common Equity
2,9882,9542,9402,7152,5102,347
Minority Interest
-6.44-6.58-6.36-8.249.3843.72
Shareholders' Equity
2,9812,9482,9332,7072,5192,391
Total Liabilities & Equity
3,5943,6543,7053,4893,5843,593
Total Debt
38.1759.2282.9293.17331.64481.87
Net Cash (Debt)
789.26863.77816.92871.71554.94285.14
Net Cash Growth
8.18%5.73%-6.29%57.08%94.62%-
Net Cash Per Share
2.002.192.122.281.450.76
Filing Date Shares Outstanding
375.18427.74383.95383.95383383
Total Common Shares Outstanding
375.18427.74383.95383383383
Working Capital
1,3121,2691,1571,2001,090948.74
Book Value Per Share
7.966.917.667.096.556.13
Tangible Book Value
2,8642,8272,8042,5872,3902,199
Tangible Book Value Per Share
7.636.617.306.756.245.74
Buildings
--1,085749.23544.4544.18
Machinery
--902.18912.39936.77936.19
Construction In Progress
--11.99160.5189.8141.11
Source: S&P Global Market Intelligence. Standard template. Financial Sources.